Krystal Biotech, Inc. - COM (KRYS)

Historical Portfolio Holders from Q3 2017 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
25 M
Holdings value Q1 2024
$4.44 B
Value change Q1 2024
+$195 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
223
Number of buys Q1 2024
122
Number of sells Q1 2024
-104
Average buys Q1 2024 %
+0.002%
Average sells Q1 2024 %
-0.002%
CUSIP
501147102
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 25 M $4.44 B +$195 M $177.93 223
2023 Q4 23.9 M $2.97 B -$11.2 M $124.06 191
2023 Q3 23.7 M $2.75 B +$92.6 M $116.00 184
2023 Q2 23 M $2.7 B +$256 M $117.40 183
2023 Q1 20.9 M $1.68 B +$9.46 M $80.06 157
2022 Q4 20.9 M $1.65 B -$15.8 M $79.22 151
2022 Q3 20.7 M $1.44 B +$2.33 M $69.70 137
2022 Q2 20.8 M $1.36 B +$17.5 M $65.66 126
2022 Q1 20.3 M $1.35 B +$79.5 M $66.54 122
2021 Q4 19.1 M $1.34 B +$208 M $69.95 132
2021 Q3 16.3 M $850 M -$12 M $52.21 117
2021 Q2 15.6 M $1.06 B -$6.34 M $68.00 114
2021 Q1 16.5 M $1.27 B +$170 M $77.04 114
2020 Q4 12.6 M $756 M -$25.5 M $60.00 101
2020 Q3 14.4 M $619 M +$11.3 M $43.05 96
2020 Q2 14.1 M $582 M +$106 M $41.42 105
2020 Q1 11.5 M $495 M -$10.5 M $43.24 85
2019 Q4 11.4 M $631 M +$15.8 M $55.38 88
2019 Q3 11.2 M $388 M +$48.4 M $34.73 80
2019 Q2 9.76 M $393 M +$131 M $40.27 72
2019 Q1 6.65 M $219 M +$15.5 M $32.90 56
2018 Q4 6.21 M $129 M +$67.9 M $20.78 45
2018 Q3 2.09 M $36.6 M -$4.98 M $17.57 20
2018 Q2 2.39 M $35.5 M -$7.83 M $14.87 15
2018 Q1 3.08 M $31 M -$1.63 M $10.09 12
2017 Q4 3.24 M $34 M +$1.03 M $10.52 13
2017 Q3 3.14 M $31.3 M +$31.3 M $9.97 13